EMRO Balance Sheet Health
Financial Health criteria checks 4/6
EMRO has a total shareholder equity of ₩38.1B and total debt of ₩15.7B, which brings its debt-to-equity ratio to 41.1%. Its total assets and total liabilities are ₩101.6B and ₩63.6B respectively. EMRO's EBIT is ₩4.2B making its interest coverage ratio 2.9. It has cash and short-term investments of ₩21.8B.
Key information
41.1%
Debt to equity ratio
₩15.66b
Debt
| Interest coverage ratio | 2.9x |
| Cash | ₩21.79b |
| Equity | ₩38.08b |
| Total liabilities | ₩63.57b |
| Total assets | ₩101.65b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A058970's short term assets (₩37.3B) do not cover its short term liabilities (₩59.9B).
Long Term Liabilities: A058970's short term assets (₩37.3B) exceed its long term liabilities (₩3.7B).
Debt to Equity History and Analysis
Debt Level: A058970 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A058970's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A058970 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A058970 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 28% per year.